Fondaparinux Sodium 55111-0679
Product NDC
55111-0679- Manufacturer
- Dr. Reddy's Laboratories Limited
- Dosage Form
- Injection
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- July 14, 2011
- Listing Expires
- December 31, 2026
- Application
- ANDA091316
Need to source Fondaparinux Sodium? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fondaparinux Sodium | 5 mg/.4mL |
Drug Class
Factor Xa Inhibitor [EPC]Factor Xa Inhibitors [MoA]
Packaging Options(2)
2 SYRINGE in 1 CARTON (55111-679-02) / .4 mL in 1 SYRINGE (55111-679-11)
10 SYRINGE in 1 CARTON (55111-679-10) / .4 mL in 1 SYRINGE (55111-679-11)